+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Isosorbide Mononitrate"

From
Isosorbide - Global Strategic Business Report - Product Thumbnail Image

Isosorbide - Global Strategic Business Report

  • Report
  • March 2024
  • 196 Pages
  • Global
From
From
From
Heart Failure with Reduced Ejection Fraction (Hfref) - Pipeline Insight - Product Thumbnail Image

Heart Failure with Reduced Ejection Fraction (Hfref) - Pipeline Insight

  • Drug Pipelines
  • September 2021
  • 60 Pages
  • Global
From
From
From
Global Isosorbide Market 2021-2025 - Product Thumbnail Image

Global Isosorbide Market 2021-2025

  • Report
  • September 2021
  • 120 Pages
  • Global
From
From
Global and Chinese Isosorbide Industry, 2021 Market Research Report - Product Thumbnail Image

Global and Chinese Isosorbide Industry, 2021 Market Research Report

  • Report
  • January 2021
  • 144 Pages
  • China, Global
From
From
From
From
Isosorbide (CAS 652-67-5) Global Market Research Report 2024 - Product Thumbnail Image

Isosorbide (CAS 652-67-5) Global Market Research Report 2024

  • Report
  • March 2024
  • 50 Pages
  • Global
From
From
  • 18 Results (Page 1 of 1)
Loading Indicator

Isosorbide Mononitrate is a cardiovascular drug used to treat and prevent angina, or chest pain. It is a nitrate that works by relaxing and widening blood vessels, allowing more oxygen-rich blood to flow to the heart. It is available in both immediate-release and extended-release forms, and is usually taken twice daily. Common side effects include headache, dizziness, and nausea. Isosorbide Mononitrate is a generic drug, and is available in many countries around the world. It is also available in combination with other drugs, such as aspirin and hydrochlorothiazide. It is often used in combination with other drugs to treat high blood pressure and heart failure. The Isosorbide Mononitrate market is highly competitive, with many companies offering generic and branded versions of the drug. Some of the major players in the market include Mylan, Teva Pharmaceuticals, Sandoz, and Pfizer. Show Less Read more